About us

In the beginning, there was a patient...

Photo by Olga Guryanova on Unsplash

Institut Georges Lopez, more often referred to as IGL, is a medical technology company specializing in the care of explanted organs and tissues.
At IGL, we design, manufacture, and market products classified as drugs or medical devices, and intended for the treatment of patients with chronic organ diseases. With years of expertise and experience, IGL is proud to be regarded as a key player in its domain.
IGL is headquartered in Lyon area (France), and consists of a network of subsidiaries located worldwide. This means we are never far from our customers and so can help them to meet their local challenges.

Mission

Our mission is to support transplant teams in lifesaving transplantation. We provide advanced solutions and systems to expand the pool of transplantable organs and improve transplant outcomes.

Leadership

A seasoned international team leveraging successful experiences in organs and tissues transplantation.

Executive Leadership

  • Alexandre Lopez, Chairman & CEO
  • Omer Uyanik, VP Product Development
  • Matthieu Proutteau, Head Pharmacist, VP Quality Assurance & Regulatory Affairs
  • Daniel Carreau, VP Industrial Operations
  • Michael Christ, VP Business Development & CEO Waters Medical Systems LLC

Regional Leadership

  • Michael Christ, Chief Executive Officer,Waters Medical Systems LLC
  • Humberto Sobrinho, General Manager, IGL America Latina
Global sites
IGL is member of
Video

Discover our history, how the company and team has grown and continues to be as close as possible to our mission.

Play Video
History

In the beginning, there was a patient… In 1987, Georges Gaston Lopez, received a kidney and liver transplant. Later, Georges Antoine Lopez, his son, founded Institut Georges Lopez (IGL), a company entirely devoted to donor organ preservation.

  • 2022

    Launch of RM4 Dual Kidney Machine Perfusion

  • 2016

    Launch of IGLbox insulated shipper for organs

  • 2015

    Pharmaceutical establishment approval, with manufacturing authorization.

  • 2014

    Acquisition of CELSIOR solution for abdominal and thoracic organs.

  • 2012

    Launch of WAVES Transportable Kidney Machine Perfusion

  • 2009

    Creation of IGL America Latina (Porto Alegre, Brazil)

  • 2007

    Initiated engagement with Waters Medical Systems (Rochester, Minnesota)

  • 2005

    Launch of IGL-1 solution for abdominal organs

  • 2003

    Creation of Institut Georges Lopez (Lyon area, France)